These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2004-000881-10 International, multicenter, randomised, open-labeled, 2-arm - Phase III Study comparing Imatinib (STI571, GlivecĀ®) Standard Dose (400 mg/day) with Imatinib High Dose Induction (800 mg/day) followed by... 2008-12-31 due-trials